Outcomes for Chronic Obstructive Pulmonary Disease Moderate Exacerbators Initiating Treatment

NCT01395875 · clinicaltrials.gov ↗

COMPLETED

Status

2849

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Fluticasone Propionate / Salmeterol Xinafoate Combination (FSC)
DRUG: Anticholinergics (AC)

Sponsor

GlaxoSmithKline